Skip To Main Content
Safia Barber on Muck Rack

Safia Barber

As seen in: The Lancet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Safia

Contact Safia, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

|
By Angela Lamarca, Daniel Palmer, Harpreet Wasan, Imperial Colllege, Daniel Palmer, Paul Ross, Yuk Ting Ma, Stephen Falk, Roopinder Gillmore, Jonathan Wadsley, Alan Anthoney, Anthony Maraveyas, Justin Waters, Claire Hobbs, Arvind Arora, Kinnari Patel, Tim Iveson, Safia Barber
| The Lancet Verified
We thank our colleagues for their observations about our ABC-06 trial comparing FOLFOX chemotherapy (folinic acid, fluorouracil, and oxaliplatin) and active symptom control (ASC) with ASC alone in patients with advanced biliary tract cancer. The ABC-06 trial stratified patients according to serum albumin, disease stage, and platinum sensitivity to first-line therapy.
Open in Who Shared View Duplicates (4) Issue with article?
See all 1 articles